UK & Canada Expand Scope Of Mutual Recognition Of GMP Inspections
Drug importers can benefit from the UK and Canada’s decision to recognize the outcomes of each other’s manufacturing inspections conducted in foreign jurisdictions.
You may also be interested in...
UK/Canada Deal Lets Drug Agencies Avoid Brexit-Related Trade Disruption
An interim trade deal between the UK and Canada means that the regulators in these countries will carry on accepting each other’s batch testing and GMP certificates.
EMA To Explain How Trial Transparency & Data Redaction Can Live Together
The European Medicines Agency is working to align the redaction and data anonymization principles underpinning two EU clinical trial transparency initiatives to ensure consistency in disclosure requirements.
ICH Consults On Modernized GCP Principles To Make Clinical Trials More Efficient
The International Council for Harmonisation has issued updated Good Clinical Practice principles to accommodate new clinical trial and data types.